Vor Biopharma
Develops licensed telitacicept for autoimmune diseases outside Greater China.
$22.65
After-hours close0.00 (0.00%)
At close$22.65(−3.74%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 74.65%40.45M sharesInsiders 0.25%133.8K sharesOther 25.10%13.60M shares
Shares outstanding 54.19M · Float —
Institutions13F, as of Mar 31, 2026
81 holders · 40.45M shares · 36 new positions · 62 increased · 8 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 5.67M | 10.47% | +5.67Mnew | May 15, 2026 |
| Ra Capital Management, L.P. | 5.40M | 9.97% | 0 | May 15, 2026 |
| FCPM Iii Services B.V. | 4.12M | 7.60% | +500.0K | May 15, 2026 |
| VR Adviser, LLC | 3.04M | 5.61% | +1.10M | May 15, 2026 |
| Frazier Life Sciences Management, L.P. | 2.54M | 4.69% | 0 | May 15, 2026 |
| Caligan Partners LP | 1.93M | 3.55% | +1,000.0K | May 15, 2026 |
| Paradigm Biocapital Advisors LP | 1.75M | 3.23% | 0 | May 15, 2026 |
| Great Point Partners LLC | 1.75M | 3.23% | +379.9K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rajeev Shahincl. RA Capital Healthcare Fund, L.P., RA Capital Management, L.P. +1 more | 19.90% | 12.94M | 13D | Jul 21, 2026 ↗ |
| Reprogrammed Interchange LLCincl. Reid Hoffman | 18.60% | 1.28M | 13D | Oct 16, 2025 ↗ |
| ForGrowth III PA B.V.incl. Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Growth III Management B.V. | 9.99% | 10.24M | 13D | Dec 23, 2025 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 9.90% | 5.08M | 13G | May 15, 2026 ↗ |
| Verve Capital Limited | 9.30% | 5.00M | 13G | May 15, 2026 ↗ |
| Frazier Life Sciences Public Fund, L.P. | 5.80% | 2.26M | 13G | Dec 19, 2025 ↗ |
| BlackRock, Inc. | 5.70% | 3.10M | 13G | Jul 30, 2026 ↗ |
| TCG Crossover GP II, LLC | 5.20% | 2.84M | 13G | Apr 1, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| TCG Crossover GP II, LLC | 10 percent owner | 2.84M | 5.23% | Apr 1, 2026 |
| Reprogrammed Interchange LLC | 10 percent owner | 1.17M | 2.15% | Oct 21, 2025 |
| Qing Che Zuraw | officer: Chief Development Officer | 46.9K | 0.09% | Jul 30, 2025 |
| Robert Ang | director, officer: PRESIDENT AND CEO | 45.6K | 0.08% | May 7, 2025 |
| Jeremy Brett Sokolove | officer: Chief Medical Officer | 27.9K | 0.05% | Apr 9, 2026 |
| Tirtha Chakraborty | officer: Chief Sci Off & Head Tech Ops | 10.9K | 0.02% | May 7, 2025 |
| Han Wook Choi | officer: Chief Financial Officer | 2.6K | 0.00% | May 2, 2025 |
| Ra Capital Management, L.P. | 10 percent owner | 1.5K | 0.00% | Aug 26, 2026 |
5 ten-percent owners hold 4.11M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 6 people have not refiled in the last 18 months (110.2K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 16, 2026 | Ra Capital Management, L.P.10 percent owner | Sale | 213 | $19.75 | 4,501,882 |
| Apr 22, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 165,150 | $15.77 | 2,402,095 |
| Apr 20, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 171,963 | $15.77 | 2,567,245 |
| Apr 17, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 458,411 | $16.28 | 2,739,208 |
| Apr 15, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 53,644 | $16.01 | 3,197,619 |
| Apr 14, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 153,735 | $15.97 | 3,251,263 |
| Apr 13, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 530,610 | $16.15 | 3,404,998 |
| Apr 10, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 828 | $15.75 | 3,935,608 |
| Apr 9, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale | 135,201 | $16.59 | 3,936,436 |
| Apr 8, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Sale · 2 lots | 484,104 | $16.48 | 4,071,637 |
CongressHouse and Senate disclosures
Not reported.